Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP674672.RAKWgVNXRc7loGn2U82Eqx800GI3GtHrBo0yE1Zgk-G9U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP674672.RAKWgVNXRc7loGn2U82Eqx800GI3GtHrBo0yE1Zgk-G9U130_assertion type Assertion NP674672.RAKWgVNXRc7loGn2U82Eqx800GI3GtHrBo0yE1Zgk-G9U130_head.
- NP674672.RAKWgVNXRc7loGn2U82Eqx800GI3GtHrBo0yE1Zgk-G9U130_assertion description "[ERCC1 and TopoIIalpha are candidate markers in predicting clinical outcome and response to treatment in LD SCLC patients and are worth of further investigation in a prospective study.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP674672.RAKWgVNXRc7loGn2U82Eqx800GI3GtHrBo0yE1Zgk-G9U130_provenance.
- NP674672.RAKWgVNXRc7loGn2U82Eqx800GI3GtHrBo0yE1Zgk-G9U130_assertion evidence source_evidence_literature NP674672.RAKWgVNXRc7loGn2U82Eqx800GI3GtHrBo0yE1Zgk-G9U130_provenance.
- NP674672.RAKWgVNXRc7loGn2U82Eqx800GI3GtHrBo0yE1Zgk-G9U130_assertion SIO_000772 18520795 NP674672.RAKWgVNXRc7loGn2U82Eqx800GI3GtHrBo0yE1Zgk-G9U130_provenance.
- NP674672.RAKWgVNXRc7loGn2U82Eqx800GI3GtHrBo0yE1Zgk-G9U130_assertion wasDerivedFrom befree-2016 NP674672.RAKWgVNXRc7loGn2U82Eqx800GI3GtHrBo0yE1Zgk-G9U130_provenance.
- NP674672.RAKWgVNXRc7loGn2U82Eqx800GI3GtHrBo0yE1Zgk-G9U130_assertion wasGeneratedBy ECO_0000203 NP674672.RAKWgVNXRc7loGn2U82Eqx800GI3GtHrBo0yE1Zgk-G9U130_provenance.